CA2323526A1 - Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation - Google Patents
Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation Download PDFInfo
- Publication number
- CA2323526A1 CA2323526A1 CA002323526A CA2323526A CA2323526A1 CA 2323526 A1 CA2323526 A1 CA 2323526A1 CA 002323526 A CA002323526 A CA 002323526A CA 2323526 A CA2323526 A CA 2323526A CA 2323526 A1 CA2323526 A1 CA 2323526A1
- Authority
- CA
- Canada
- Prior art keywords
- protein
- hpv
- formulation according
- formulation
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
L'invention concerne une formulation qui contient au moins une protéine spécifique des papillomavirus et environ 0,3 à 4 M d'un sel à un pH compris entre 7,3 et 7,45 environ.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19812940.8 | 1998-03-24 | ||
DE19812940A DE19812940A1 (de) | 1998-03-24 | 1998-03-24 | Formulierung mit Papillomavirus-spezifischem Protein, seine Herstellung und Verwendung |
PCT/EP1999/001999 WO1999048917A2 (fr) | 1998-03-24 | 1999-03-24 | Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2323526A1 true CA2323526A1 (fr) | 1999-09-30 |
Family
ID=7862147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002323526A Abandoned CA2323526A1 (fr) | 1998-03-24 | 1999-03-24 | Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1066321A2 (fr) |
JP (1) | JP2002507625A (fr) |
AR (1) | AR014969A1 (fr) |
AU (1) | AU3598999A (fr) |
CA (1) | CA2323526A1 (fr) |
DE (1) | DE19812940A1 (fr) |
MX (1) | MXPA00009283A (fr) |
WO (1) | WO1999048917A2 (fr) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1213299A1 (fr) * | 2000-12-08 | 2002-06-12 | Leids Universitair Medisch Centrum | Epitopes immunogènes du papillomavirus humains et leurs usages |
EP1355925A2 (fr) * | 2000-12-08 | 2003-10-29 | Academisch Ziekenhuis Leiden | Peptides longs de 22-45 residus d'acides amines induisant et/ou stimulant les reponses immunitaires specifiques de l'antigene |
AU2002219711B8 (en) | 2000-12-08 | 2006-03-02 | Academisch Ziekenhuis Leiden | Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses |
US7901921B2 (en) * | 2004-10-22 | 2011-03-08 | Oncolytics Biotech Inc. | Viral purification methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
SE9001705D0 (sv) * | 1990-05-11 | 1990-05-11 | Medscand Ab | Saett foer diagnostik av virusbaerande tumoerer genom immunoassay |
DE4447664C2 (de) * | 1994-10-07 | 1999-04-15 | Lutz Prof Dr Gissmann | Fusionsproteine, Verfahren zu deren Herstellung sowie deren Anwendung |
CA2202090C (fr) * | 1994-10-07 | 2012-04-17 | Lutz Gissmann | Particules semblables au virus du papillome, proteines de fusion et leur procede de production |
-
1998
- 1998-03-24 DE DE19812940A patent/DE19812940A1/de not_active Withdrawn
-
1999
- 1999-03-24 AU AU35989/99A patent/AU3598999A/en not_active Abandoned
- 1999-03-24 EP EP99917850A patent/EP1066321A2/fr not_active Withdrawn
- 1999-03-24 MX MXPA00009283A patent/MXPA00009283A/es unknown
- 1999-03-24 CA CA002323526A patent/CA2323526A1/fr not_active Abandoned
- 1999-03-24 AR ARP990101311A patent/AR014969A1/es unknown
- 1999-03-24 JP JP2000537899A patent/JP2002507625A/ja active Pending
- 1999-03-24 WO PCT/EP1999/001999 patent/WO1999048917A2/fr not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU3598999A (en) | 1999-10-18 |
MXPA00009283A (es) | 2002-12-13 |
DE19812940A1 (de) | 1999-10-07 |
WO1999048917A2 (fr) | 1999-09-30 |
EP1066321A2 (fr) | 2001-01-10 |
AR014969A1 (es) | 2001-04-11 |
JP2002507625A (ja) | 2002-03-12 |
WO1999048917A3 (fr) | 1999-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6228368B1 (en) | Papilloma virus capsomere formulations and method of use | |
EP1305039B1 (fr) | Formes (fixes) stables de proteines l1 virales capsidiales et de proteines virales capsidiales hybrides et leurs utilisations | |
US6352696B1 (en) | Papillomavirus truncated L1 protein and fusion protein constructs | |
US6649167B2 (en) | Papillomavirus truncated L1 protein and fusion protein constructs | |
US6991795B1 (en) | Protein delivery system using human papillomavirus virus-like particles | |
AU753391B2 (en) | Protein delivery system using human papillomavirus virus-like particles | |
US7182947B2 (en) | Papillomavirus truncated L1 protein and fusion protein constructs | |
CA2323526A1 (fr) | Formulation contenant une proteine specifique des papillomavirus, sa fabrication et son utilisation | |
AU755242B2 (en) | Medicament for preventing or treating papilloma virus-specific tumors | |
US6926897B1 (en) | Medicament for the avoidance or treatment of papillomavirus-specific tumour | |
US7494658B2 (en) | Papilloma virus truncated L1 protein and fusion protein constructs | |
MXPA00003358A (en) | Papilloma virus capsomere vaccine formulations and methods of use | |
DE29824556U1 (de) | Formulierung mit Papillomavirus-spezifischem Protein | |
AU4447999A (en) | Chimeric papillomavirus-like particles |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |